Safety and Effectiveness Study of the Solysafe Septal Occluder in Patients With Atrial Septum Defect and Patent Foramen Ovale
NACompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
Atrial Septal DefectPatent Foramen Ovale
Interventions
DEVICE
Solysafe Septal Occluder
Trial Locations (1)
13353
German Heart Institute, Berlin
All Listed Sponsors
lead
Carag AG
INDUSTRY
NCT00207376 - Safety and Effectiveness Study of the Solysafe Septal Occluder in Patients With Atrial Septum Defect and Patent Foramen Ovale | Biotech Hunter | Biotech Hunter